Mary Cambou is an Infectious Disease physician affiliated with University of California, Los Angeles. OpenAlex indexes 64 publications with 808 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1399 Roxbury Dr Ste 100
Los Angeles, CA 900354709
Telephone
310-557-2273Provider last certified this registry record 25 Jul 2022.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
26.9%Protease Inhibitor10.9%Prezcobix100%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor8.3%Isentress100%Part D<11 patients+ 1 more class in this area
Cardiovascular
24.4%Calcium channel blocker8.3%Amlodipine Besylate100%Part D<11 patientsStatin8.3%Atorvastatin Calcium100%Part D<11 patients+ 1 more class in this area
Nervous system
21.2%Aminoketone13.5%Bupropion Xl100%Part D<11 patientsNonergot Dopamine Agonist7.7%Pramipexole Dihydrochloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- SARS-CoV-2 in Pregnancy: Comparison of Natural Infection and Hybrid Immunity in Mother-Infant Pairs
University of California Los Angeles
FY2026$203,580K23AI177952 - SARS-CoV-2 in Pregnancy: Comparison of Natural Infection and Hybrid Immunity in Mother-Infant Pairs
University of California Los Angeles
FY2025$203,580K23AI177952 - SARS-CoV-2 in Pregnancy: Comparison of Natural Infection and Hybrid Immunity in Mother-Infant Pairs
University of California Los Angeles
FY2024$203,580K23AI177952
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”